XML 42 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Financial Results (Notes)
 12 Months Ended
Jun. 30, 2014
Summarized Quarterly Results of Continuing Operations [Abstract]  
Quarterly Financial Results
NOTE 16. QUARTERLY FINANCIAL RESULTS (UNAUDITED)

Summarized quarterly results of our continuing operations for the two fiscal years ended June 30, 2014 and June 30, 2013 are as follows:

 
 
First
Quarter
 
Second Quarter
 
Third
Quarter
 
Fourth
Quarter (A)
Year ended June 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
2,834.8

 
$
2,977.9

 
$
3,320.0

 
$
3,073.7

Costs of revenues
 
$
1,721.7

 
$
1,769.8

 
$
1,884.4

 
$
1,845.6

Gross profit
 
$
1,113.1

 
$
1,208.1

 
$
1,435.6

 
$
1,228.1

Net earnings from continuing operations
 
$
327.7

 
$
375.8

 
$
510.4

 
$
288.7

Basic earnings per share from continuing operations
 
$
0.68

 
$
0.79

 
$
1.07

 
$
0.60

Diluted earnings per share from continuing operations
 
$
0.68

 
$
0.78

 
$
1.06

 
$
0.60

 
 
 
 
 
 
 
 
 
 
 
First
Quarter
 
Second Quarter
 
Third
Quarter
 
Fourth
Quarter (B)
Year ended June 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenues
 
$
2,632.7

 
$
2,742.8

 
$
3,109.3

 
$
2,802.8

Costs of revenues
 
$
1,583.7

 
$
1,621.6

 
$
1,743.2

 
$
1,689.9

Gross profit
 
$
1,049.0

 
$
1,121.2

 
$
1,366.1

 
$
1,112.9

Net earnings from continuing operations
 
$
301.7

 
$
350.9

 
$
481.6

 
$
224.0

Basic earnings per share from continuing operations
 
$
0.62

 
$
0.73

 
$
1.00

 
$
0.46

Diluted earnings per share from continuing operations
 
$
0.62

 
$
0.72

 
$
0.99

 
$
0.46



(A) Net earnings from continuing operations, basic earnings per share from continuing operations and diluted earnings per share from continuing operations include the impact of separation costs related to the planned separation of the Company's Dealer Services business, which decreased net earnings from continuing operations by $14.9 million and both basic and diluted earnings per share from continuing operations by $0.03.

(B) Net earnings from continuing operations and diluted earnings per share from continuing operations includes the impact of a goodwill impairment charge related to ADP AdvancedMD, which decreased net earnings from continuing operations by $42.7 million and both basic and diluted earnings per share from continuing operations by $0.09.